1. Effects of tyrosine kinase inhibitors on androgen, estrogen α, glucocorticoid and thyroid receptors
   Maša Kenda et al, 2022, Toxicology and Applied Pharmacology CrossRef
2. Functionally analyzing the important roles of hepatocyte nuclear factor 3 (FoxA) in tumorigenesis
   Bing Gao et al, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
3. Endometrial Cancer in Aspect of Forkhead Box Protein Contribution
   Olga Adamczyk-Gruszka et al, 2022, International Journal of Environmental Research and Public Health CrossRef
4. Aurora kinase A and B as new treatment targets in aromatase inhibitor-resistant breast cancer cells
   Stine Hole et al, 2015, Breast Cancer Research and Treatment CrossRef
5. Design, synthesis and biological evaluation of a new thieno[2,3-d]pyrimidine-based urea derivative with potential antitumor activity against tamoxifen sensitive and resistant breast cancer cell lines
   Marwa Sharaky et al, 2020, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
6. MicroRNA-Based Discovery of Biomarkers, Therapeutic Targets, and Repositioning Drugs for Breast Cancer
   Qing Ye et al, 2023, Cells CrossRef
7. Breast Cancer Subtypes Based on Hypoxia-Related Gene Sets Identify Potential Therapeutic Agents
   Zhenchong Xiong et al, 2022, Frontiers in Molecular Biosciences CrossRef
8. New cell culture model for aromatase inhibitor-resistant breast cancer shows sensitivity to fulvestrant treatment and cross-resistance between letrozole and exemestane
   STINE HOLE et al, 2015, International Journal of Oncology CrossRef
9. Sorafenib for the treatment of breast cancer
   Giuseppe Bronte et al, 2017, Expert Opinion on Pharmacotherapy CrossRef
10. Sphingolipids as Mediators of Breast Cancer Progression, Metastasis, Response and Resistance to Chemotherapy
    Benjamin Newcomb et al, 2015, Bioactive Sphingolipids in Cancer Biology and Therapy CrossRef
11. Copper-related genes predict prognosis and characteristics of breast cancer
    Yi Liu et al, 2023, Frontiers in Immunology CrossRef
12. Inferences of drug responses in cancer cells from cancer genomic features and compound chemical and therapeutic properties
    Yongcui Wang et al, 2016, Scientific Reports CrossRef
13. Src Drives Growth of Antiestrogen Resistant Breast Cancer Cell Lines and Is a Marker for Reduced Benefit of Tamoxifen Treatment
    Sarah L. Larsen et al, 2015, PLOS ONE CrossRef
14. Integrated bioinformatics and statistical approaches to explore molecular biomarkers for breast cancer diagnosis, prognosis and therapies
    Md. Shahin Alam et al, 2022, PLOS ONE CrossRef
15. Sorafenib improves alkylating therapy by blocking induced inflammation, invasion and angiogenesis in breast cancer cells
    Alfeu Zanotto-Filho et al, 2018, Cancer Letters CrossRef